Skip to main content
U.S. flag

An official website of the United States government

Notice:

The National Institute of Corrections is currently assessing its website and materials in accordance with recent Executive Orders and related guidance. During this review, some of NIC’s webpages and publications may be temporarily unavailable. Please revisit this web page for updates.

Clinical Pearls Series: Harm Reduction and Re-entry Program

Event Date
to
Duration
1 hour

Webinar Summary: 

Commander Beth Thompson, National Lead for the Federal Bureau of Prisons HIV Pharmacy Consultants, and Lieutenant Commander Alyson Dunlavey, a Transitional Care Pharmacist, illustrate the significance of harm reduction in the correctional setting. Join these clinical pharmacists as they identify strategies to implement harm reduction programs that combat substance use and infectious disease syndemics in the correctional setting and promote successful reintegration of incarcerated adults into society.

This webinar is part of the National Institute of Corrections Clinical Pearls series. The series explores how to integrate clinical pharmacists into primary care. Session participants will learn how to identify best practices for carceral team medicine and clinical pearls in disease states affecting adults in custody.

Register for the EVENT

Webinar Learning Objectives:

During this 60-minute webinar, participants will:

  1. Explain the principles of harm reduction and the significance of harm reduction in the correctional setting.
  2. Identify evidence-based harm reduction programs that reduce the risk of opioid overdose and HIV transmission upon reentry to the community.
  3. Discuss common obstacles to implementing harm reduction in correctional facilities and propose solutions for overcoming challenges.

Series Take Aways:  

During this webinar series, participants will:

  • Define the continuum of opportunities for pharmacist integration in clinical practice.
  • Analyze different correctional systems to determine where pharmacists can be included to develop more efficient operations within correctional facilities, reducing costs, improving decision-making processes, enhancing safety, and optimizing resource allocation.
  • Evaluate the current strategies of disease management within the carceral setting and analyze novel approaches to improve patient care, decrease costs, and optimize resource allocation.
  • Envision how implementing novel strategies for the management of complex disease processes can enhance the operation of a correctional institution through technology and a paradigm change, optimizing screening and treatment practices.
  • Formulate strategies to use various healthcare disciplines that encourage a collaborative, team approach.

Frequently Asked Questions:

Educator Bios

  • Lieutenant Commander Dunlavey

     LCDR Dunlavey

    LCDR Dunlavey has over 8 years of experience as a pharmacist with the United States Public Health Service. Her career began with the Indian Health Service in Claremore, OK where she completed a PGY-1 pharmacy practice residency and remained as an inpatient clinical pharmacist for four years. She then transferred to the Federal Bureau of Prisons where she served as staff pharmacist at FCI Elkton and managed a MAT clinic of over sixty patients. LCDR Dunlavey currently serves as a transitional care pharmacist with the FBOP Central Office. Her collateral duties include participating as a member of the FBOP Continuing Education and Pharmacovigilance Advisory Groups and serving as a Regional Substance Use Disorder Clinical Pharmacist Consultant.

  • Commander Beth Thompson 

    CDR Beth Thompson

    LCDR Dunlavey has over 8 years of experience as a pharmacist with the United States Public Health Service. Her career began with the Indian Health Service in Claremore, OK where she completed a PGY-1 pharmacy practice residency and remained as an inpatient clinical pharmacist for four years. She then transferred to the Federal Bureau of Prisons where she served as staff pharmacist at FCI Elkton and managed a MAT clinic of over sixty patients. LCDR Dunlavey currently serves as a transitional care pharmacist with the FBOP Central Office. Her collateral duties include participating as a member of the FBOP Continuing Education and Pharmacovigilance Advisory Groups and serving as a Regional Substance Use Disorder Clinical Pharmacist Consultant.

female officer class
Division hosting this event
  • Created: Updated: